Wine.

Alcohol stimulates gastric acid secretion and reduces hepcidin, both of which favour iron uptake, and heavier drinkers show higher ferritin on average. At the same time the tannins and anthocyanins in red wine chelate non-heme iron in the lumen. Which effect dominates depends on the wine, the meal and the drinker. Anyone managing iron overload should not read the polyphenol side as protective.

Alcohol reduces intestinal folate absorption through the proton coupled folate transporter, impairs hepatic retention, and increases urinary loss. Regular intake therefore lowers folate status through three routes at once. This is one of the better characterised nutrient interactions in the alcohol literature. It matters most for people whose intake is already marginal.

Alcohol inhibits the thiamine transporters THTR1 and THTR2 and reduces hepatic thiamine pyrophosphokinase activity, which converts thiamine to its active diphosphate form. Body stores of thiamine are small and turn over in weeks, so the depletion appears faster than for most vitamins. This is textbook clinical nutrition rather than an emerging finding.

Alcohol causes magnesuria within hours of intake by reducing tubular reabsorption. Regular intake at higher volumes therefore drags magnesium status down over time. The same tubular effect applies to potassium and zinc. This is a straightforward renal handling effect and not a claim about any outcome.

Ethanol shortens sleep onset but suppresses REM in the first half of the night and fragments the second half. Melatonin taken alongside it adds a separate sedating input without correcting the architecture disruption. The combination generally produces sleep that feels earlier and is worse. Read this as a reason to separate them rather than a pairing.

Red wine contains trans-resveratrol at roughly single digit milligrams per litre, while supplements deliver hundreds of milligrams. The supplemental dose dwarfs anything a glass provides, which is the central problem with reading resveratrol research back onto wine drinking. Both are extensively glucuronidated and sulfated on first pass, so plasma exposure of the free compound stays low either way. The two are not equivalent inputs.

Quercetin is itself present in wine, and supplemental quercetin inhibits several CYP isoforms including CYP3A4 and CYP2C9. Chronic ethanol intake induces CYP2E1. The net effect on any co-administered drug is not predictable from either ingredient alone. Flagging the overlap is more useful than guessing the direction.

Grape seed extract concentrates the oligomeric proanthocyanidins that red wine carries in dilute form, and delivers them without alcohol. For anyone interested in the polyphenol side of the wine story, this is where that fraction lives in usable quantity. The extract is not a substitute for wine in any research sense, because the studies on each used different preparations at different doses.

Alcohol related gastric mucosal change reduces intrinsic factor secretion, and heavy intake also affects ileal receptor mediated uptake. Serum B12 can stay misleadingly normal because hepatic release masks depleted stores, so methylmalonic acid is the more informative marker in this context. This is a chronic intake effect, not a single glass effect.

Acetaldehyde generated during ethanol metabolism consumes glutathione, and NAC provides the rate limiting precursor for resynthesis. The biochemistry is solid, established in the clinical use of NAC for acetaminophen overdose. Whether taking NAC alongside social drinking changes any measurable outcome has not been shown, and it should not be read as offsetting alcohol intake.

Wine carries biogenic amines from malolactic fermentation, chiefly histamine, tyramine and putrescine, in amounts that vary widely by production method. Ascorbate is a recognised nitrosation inhibitor in food chemistry. This addresses one narrow chemical reaction and says nothing about histamine sensitivity, which is a separate mechanism involving diamine oxidase capacity.

Histamine and other biogenic amines from bacterial decarboxylation during malolactic fermentation are broken down at the gut mucosa by diamine oxidase. People with low DAO activity, including those on DAO inhibiting medication, clear them poorly. Supplemental DAO is available and the rationale is coherent, though controlled evidence for it in wine specifically is limited. Alcohol itself also inhibits DAO, which works against the strategy.

Acetaldehyde displaces pyridoxal 5-phosphate from its binding proteins, leaving it exposed to phosphatase degradation and faster clearance. The result is lower circulating active B6 with regular intake. Since PLP is the cofactor for transaminases and for parts of the homocysteine pathway, the knock on effects are broad rather than narrow. This is established biochemistry.

Regular ethanol intake raises urinary zinc excretion and reduces uptake at the enterocyte. Zinc is also a cofactor for alcohol dehydrogenase, so the pathway that clears ethanol depends on the mineral the ethanol is depleting. The circularity is real but the practical point is simple, which is that habitual intake lowers zinc status.